A pivotal phase 3 trial of Ximycin for the prevention of surgical site infections in patients in elective colorectal surgery.
Phase of Trial: Phase III
Latest Information Update: 15 Jan 2018
Price : $35 *
At a glance
- Drugs Gentamicin/vancomycin (Primary)
- Indications Postoperative infections
- Focus Registrational; Therapeutic Use
- Sponsors Armis Biopharma
- 15 Jan 2018 New trial record
- 09 Jan 2018 According to a Armis Biopharma media release, this trial may initiate in 2018.